Market Closed -
Borsa Istanbul
11:09:50 2024-06-04 am EDT
|
5-day change
|
1st Jan Change
|
14.65
TRY
|
-1.41%
|
|
-3.68%
|
-27.11%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
703.2
|
1,825
|
4,340
|
12,788
|
95,179
|
50,853
|
Enterprise Value (EV)
1 |
1,040
|
2,242
|
5,322
|
14,946
|
100,943
|
61,402
|
P/E ratio
|
6.62
x
|
6.25
x
|
23
x
|
30.7
x
|
63.3
x
|
-57.9
x
|
Yield
|
5.34%
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.41
x
|
2.49
x
|
4.28
x
|
6.33
x
|
18.2
x
|
8.42
x
|
EV / Revenue
|
2.09
x
|
3.06
x
|
5.25
x
|
7.4
x
|
19.3
x
|
10.2
x
|
EV / EBITDA
|
5.64
x
|
8.85
x
|
21
x
|
27.6
x
|
61.7
x
|
-130
x
|
EV / FCF
|
-3.43
x
|
-12.3
x
|
-9.36
x
|
-9.83
x
|
-22.5
x
|
-21.7
x
|
FCF Yield
|
-29.2%
|
-8.1%
|
-10.7%
|
-10.2%
|
-4.44%
|
-4.61%
|
Price to Book
|
2.82
x
|
3.6
x
|
6.23
x
|
9.06
x
|
27.3
x
|
6.74
x
|
Nbr of stocks (in thousands)
|
221,085
|
663,255
|
663,255
|
1,240,000
|
2,530,000
|
2,530,000
|
Reference price
2 |
3.181
|
2.752
|
6.543
|
10.31
|
37.62
|
20.10
|
Announcement Date
|
2/19/19
|
2/12/20
|
2/4/21
|
2/11/22
|
2/15/23
|
3/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
497.1
|
732.7
|
1,014
|
2,021
|
5,237
|
6,039
|
EBITDA
1 |
184.3
|
253.4
|
253.7
|
541.6
|
1,636
|
-473.9
|
EBIT
1 |
178.9
|
246.1
|
240.7
|
508.6
|
1,576
|
-853.9
|
Operating Margin
|
35.99%
|
33.6%
|
23.74%
|
25.17%
|
30.09%
|
-14.14%
|
Earnings before Tax (EBT)
1 |
118.2
|
145.4
|
158.9
|
334.3
|
544.7
|
-1,515
|
Net income
1 |
106.2
|
145.6
|
188.3
|
325.8
|
802.3
|
-878.2
|
Net margin
|
21.36%
|
19.87%
|
18.58%
|
16.12%
|
15.32%
|
-14.54%
|
EPS
2 |
0.4803
|
0.4400
|
0.2839
|
0.3362
|
0.5943
|
-0.3471
|
Free Cash Flow
1 |
-303.6
|
-181.6
|
-568.3
|
-1,520
|
-4,484
|
-2,832
|
FCF margin
|
-61.07%
|
-24.79%
|
-56.06%
|
-75.21%
|
-85.61%
|
-46.89%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1700
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/19/19
|
2/12/20
|
2/4/21
|
2/11/22
|
2/15/23
|
3/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
337
|
417
|
982
|
2,158
|
5,764
|
10,549
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.828
x
|
1.646
x
|
3.872
x
|
3.985
x
|
3.524
x
|
-22.26
x
|
Free Cash Flow
1 |
-304
|
-182
|
-568
|
-1,520
|
-4,484
|
-2,832
|
ROE (net income / shareholders' equity)
|
54.1%
|
38.5%
|
31.3%
|
29.8%
|
32%
|
-11.3%
|
ROA (Net income/ Total Assets)
|
22.1%
|
16.1%
|
9.23%
|
9.43%
|
11.6%
|
-2.19%
|
Assets
1 |
480.5
|
905.7
|
2,040
|
3,456
|
6,906
|
40,046
|
Book Value Per Share
2 |
1.130
|
0.7600
|
1.050
|
1.140
|
1.380
|
2.980
|
Cash Flow per Share
2 |
0.0600
|
0.2700
|
0.1100
|
0.0800
|
0.6100
|
1.830
|
Capex
1 |
31.6
|
135
|
214
|
585
|
1,036
|
2,384
|
Capex / Sales
|
6.36%
|
18.4%
|
21.12%
|
28.94%
|
19.78%
|
39.48%
|
Announcement Date
|
2/19/19
|
2/12/20
|
2/4/21
|
2/11/22
|
2/15/23
|
3/29/24
|
Last Close Price
14.65
TRY Average target price
17.2
TRY Spread / Average Target +17.41% Consensus |
1st Jan change
|
Capi.
|
---|
| -27.11% | 1.17B | | -.--% | 11.51B | | -10.15% | 7.36B | | +2.25% | 6.65B | | -4.95% | 6.11B | | -4.15% | 5.79B | | -20.79% | 5.46B | | +33.65% | 5.19B | | -15.57% | 4.77B | | +5.14% | 3.93B |
Other Agricultural Chemicals
|